GTBP
GT Biopharma·NASDAQ
--
--(--)
--
--(--)
7.55 / 10
Outperform
Fund flow analysis registers a strong 7.55/10, indicating robust liquidity inflow. Although overall, block, small, medium, large, and extra-large flows all display negative trends, the high fund-flow score suggests underlying buying interest that could support price stabilization. This positive liquidity contrasts with the neutral technical and fundamental signals, offering a potential catalyst if fundamentals improve.
Fund Flow Rating
What is the market sentiment for GTBP?
- GTBP holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.55/10 (Outperform).
